Challenges in Clinical Trial Patient Recruitment & Strategies To Overcome Them
When recruitment falls behind schedule, the consequences can be significant. Delays to enrollment often extend study timelines, increase operational costs, postpone regulatory submissions, and ultimately slow patient access to potentially life-changing new treatments.
However, successful recruitment is no longer simply about identifying eligible participants. Organizations must also engage diverse patient populations, build trust, communicate complex information clearly, and keep participants informed and motivated throughout the clinical trial process.
In this article, we'll explore the current challenges in clinical trial patient recruitment and enrollment, along with practical strategies that can help improve recruitment outcomes and support successful study delivery.
Contents
- Why Patient Recruitment Is So Critical to Clinical Trial Success
- Challenge 1: Strict Eligibility Criteria
- Challenge 2: Limited Patient Awareness & Understanding
- Challenge 3: Reaching Diverse Patient Populations
- Challenge 4: Building Patient Trust
- Challenge 5: Geographic & Logistical Barriers
- Challenge 6: Patient Retention Throughout the Trial
- Why Language & Localization Can Make or Break Recruitment
Why Patient Recruitment Is So Critical to Clinical Trial Success
Every clinical trial depends on recruiting enough eligible participants within the planned timeframe. Without sufficient enrollment, studies can be delayed or even terminated before they generate the evidence needed to evaluate a treatment's safety and effectiveness.
Recruitment delays create a ripple effect throughout the clinical research lifecycle, extending study timelines, increasing costs, delaying regulatory submissions, and slowing patient access to new therapies.
Successful recruitment is about more than meeting enrollment targets. Recruiting participants from diverse backgrounds helps create study populations that better reflect real-world patients, producing stronger clinical evidence and supporting broader regulatory approvals.
To achieve this, many organizations are adopting a more patient-centric approach to trial design. By reducing barriers to participation, improving communication, and creating a better participant experience, patient-centric strategies can strengthen both recruitment and retention.
Challenge 1: Strict Eligibility Criteria
Carefully defined inclusion and exclusion criteria are essential for protecting patient safety and ensuring clinical trial results are scientifically valid. However, as study protocols become increasingly complex, the pool of eligible participants often becomes much smaller.
Many patients who initially express interest ultimately fail screening because they do not meet all of the study requirements. This challenge is even greater in trials for rare diseases or those requiring highly specific treatment histories or disease characteristics, where suitable participants can be difficult to identify.
Strategies To Overcome This Challenge
While eligibility criteria must always support patient safety and study objectives, sponsors can improve recruitment by reviewing protocol requirements during study design to remove unnecessary restrictions where appropriate.
Conducting feasibility assessments and analyzing real-world evidence can help determine whether recruitment targets are realistic before a trial begins. Electronic health records and AI-assisted patient matching can also help identify eligible participants more efficiently, while close collaboration with investigators enables potential candidates to be identified and screened earlier in the recruitment process.
Challenge 2: Limited Patient Awareness & Understanding
Many clinical trials struggle to recruit participants simply because eligible patients are unaware that relevant studies exist. Even when patients are informed about a trial, misconceptions about clinical research – such as concerns over safety or fears of being treated as "test subjects" – can discourage participation.
Communication also plays a significant role. Recruitment materials that rely on technical or scientific language can be difficult for patients to understand, making them less likely to engage with a study or provide informed consent. Using plain language helps patients better understand what participation involves, enabling them to make informed decisions with confidence.
Strategies To Overcome This Challenge
Organizations can improve recruitment by developing clear and patient-friendly educational materials that explain clinical trials in accessible language. Educational campaigns delivered across multiple channels – including websites, videos, brochures, FAQs, social media, and digital advertising – can also increase awareness and reach a wider audience.
For multinational studies, it's equally important that recruitment materials are accurately translated and culturally adapted. Localized, patient-friendly communications help ensure eligible participants fully understand the opportunity regardless of their language or cultural background, supporting more inclusive recruitment and informed participation.
Explore Patient Recruitment & Retention Translations
Challenge 3: Reaching Diverse Patient Populations
Diversity has become a priority in modern clinical research. Recruiting participants from a broad range of backgrounds helps ensure clinical trial results better reflect the patients who will ultimately use a treatment, leading to stronger evidence and greater confidence in its safety and effectiveness across different populations.
However, many studies have historically underrepresented minority ethnic groups, older adults, rural communities, and people with limited English proficiency. This lack of representation can reduce the generalizability of study findings and, in some cases, limit regulatory approvals or the ability to understand how treatments perform across diverse patient populations. As a result, regulators are placing greater emphasis on representative participant recruitment.
Strategies To Overcome This Challenge
Improving diversity requires recruitment strategies that actively engage underrepresented communities. Community outreach initiatives, partnerships with patient advocacy groups and local healthcare providers, and multilingual recruitment campaigns can all help broaden participation and build trust with prospective patients.
Equally important is ensuring recruitment materials are culturally appropriate as well as linguistically accurate. Rather than simply translating words, localization adapts content, imagery, tone, and messaging to reflect the expectations and cultural context of different audiences. This helps recruitment materials resonate more effectively with diverse communities, improving understanding and engagement throughout the recruitment process.
Challenge 4: Building Patient Trust
Trust is one of the most important factors influencing whether a patient chooses to participate in a clinical trial. Many prospective participants have understandable concerns about data privacy, safety, informed consent, and the risks associated with receiving an investigational treatment.
These concerns can be heightened when recruitment materials are inconsistent or difficult to understand. If patients are unsure what participation involves or feel they are not receiving clear information, they are far less likely to enroll.
Strategies To Overcome This Challenge
Building trust starts with transparent and consistent communication throughout the recruitment process. Clear informed consent documentation and straightforward explanations of study procedures from investigators can help patients confidently make informed decisions.
Providing accessible educational resources – including brochures, FAQs, videos, and online content – can further address common concerns and improve understanding. For global studies, it’s equally important that translated materials accurately convey the study’s risks, benefits, and expectations without ambiguity, ensuring every patient receives reliable information regardless of their preferred language.
Challenge 5: Geographic & Logistical Barriers
Even when patients are eligible and willing to participate, practical barriers can prevent enrollment. Travel requirements, time commitments, work schedules, and childcare responsibilities can all make participation difficult, particularly for studies requiring frequent site visits.
Access can be an even greater challenge when specialist trial sites are located far from eligible participants. In fact, around 70% of eligible patients in the United States live more than two hours from an investigative site, limiting opportunities to take part in clinical research.
To help address these challenges, many sponsors are adopting decentralized clinical trials (DCTs), which reduce the need for in-person visits by bringing aspects of the study closer to patients.
Strategies To Overcome This Challenge
Decentralized approaches can make participation more convenient through remote patient visits, telemedicine appointments, home healthcare services, and electronic consent (eConsent). Flexible scheduling and digital communication platforms also help reduce the burden on participants while improving engagement throughout the study.
As trials become increasingly digital, it's equally important that patient-facing materials are accessible to every participant. Localized digital resources – including mobile app content, eConsent documentation, patient portals, and study communications – help ensure patients can confidently understand and engage with the trial, regardless of their language or location.
Challenge 6: Patient Retention Throughout the Trial
Recruitment is only the first step towards a successful clinical trial. Retaining participants throughout the study is equally important, as patient withdrawals can reduce data quality and increase the need to recruit replacement participants.
Participants may discontinue a trial for many reasons, including unexpected time commitments, changes in their health, concerns about side effects, or simply feeling disconnected from the study. Maintaining engagement throughout the participant journey is therefore essential to trial success.
Strategies To Overcome This Challenge
Effective retention strategies focus on keeping participants informed, supported, and engaged from enrollment through study completion. Regular communication and patient engagement initiatives all help participants feel connected and informed throughout the trial.
Providing patient-friendly materials at every stage of the study also improves the participant experience. For multinational trials, ongoing multilingual support and professionally localized communications ensure patients continue to receive accurate, accessible information in their preferred language, helping to reduce misunderstandings and encourage long-term participation.
Why Language & Localization Can Make or Break Recruitment
For many patients, recruitment materials provide their first impression of a clinical trial. Whether it's a social media advertisement or informed consent document, these resources play a key role in shaping how patients understand the study and whether they feel confident enough to participate.
Clinical trial communications must be medically accurate, comply with local regulatory requirements, and be adapted to the cultural expectations and health literacy levels of each target audience. A literal translation may preserve the words, but it can still create confusion or fail to resonate with prospective participants.
High-quality localization addresses these challenges by ensuring patient-facing content is culturally appropriate and easy to understand without compromising scientific accuracy. From recruitment campaigns to ongoing study communications, localized content helps patients make informed decisions and remain engaged throughout the clinical trial journey.
Ultimately, effective translation and localization support every stage of patient recruitment and retention. By improving understanding and making clinical trials more accessible to diverse populations, organizations can strengthen enrollment, improve participant retention, meet changing regulatory expectations, and generate more representative data to support broader approvals.
Support Better Clinical Trial Recruitment With Conversis
Effective clinical trial recruitment starts with accessible communication. At Conversis, an IQVA business, we help clinical research organizations translate and localize patient recruitment and retention materials, enabling them to engage diverse patient populations while supporting medical accuracy and regulatory compliance.
Contact our experts to learn how expert language solutions can strengthen engagement and support more successful clinical trials.
